| 2026-03-17 | Sarissa Capital Management LPUnternehmen | -6,73M | 20,53M | Verkauf | 3,05 - 3,31 | 9,19M | -42,28% |
| 2026-02-23 | Ms. Tammi GaskinsSVP & Chief Commercial Officer. | -21,53k | 80,33k | Verkauf | 3,66 - 3,81 | 213,74k | -9,15% |
| 2026-02-23 | Mr. Ronald SilverSenior VP, Interim CFO, Corporate Controller & CAO | -24,17k | 90,21k | Verkauf | 3,66 - 3,81 | 109,47k | -18,09% |
| 2026-02-23 | Mr. Gregory MartiniInsider | -21,94k | 81,89k | Verkauf | 3,66 - 3,81 | 77,27k | -22,12% |
| 2026-02-23 | Mr. Thomas A. McCourtCEO & Director | -198,28k | 739,93k | Verkauf | 3,66 - 3,81 | 629,98k | -23,94% |
| 2026-02-23 | Dr. Michael ShetzlineChief Medical Officer, Senior VP and Head of Research & Drug Development | -32,58k | 121,59k | Verkauf | 3,66 - 3,81 | 338,92k | -8,77% |
| 2026-02-23 | Mr. John MinardoSenior VP, Chief Legal Officer & Secretary | -36,49k | 136,18k | Verkauf | 3,66 - 3,81 | 195,29k | -15,74% |
| 2026-01-05 | Mr. Ronald SilverSenior VP, Interim CFO, Corporate Controller & CAO | -35,42k | 162,91k | Automatic Disposition | 4,60 | 93,50k | -27,47% |
| 2025-11-17 | Ms. Tammi GaskinsSVP & Chief Commercial Officer. | -6,02k | 19,97k | Verkauf | 3,32 | 235,26k | -2,49% |
| 2025-08-11 | Ms. Tammi GaskinsSVP & Chief Commercial Officer. | -1,32k | 1,11k | Verkauf | 0,84 | 241,28k | -0,54% |
| 2025-08-11 | Mr. Ronald SilverSenior VP, Interim CFO, Corporate Controller & CAO | -2,85k | 2,39k | Verkauf | 0,84 | 89,50k | -3,08% |
| 2025-08-11 | Mr. John MinardoSenior VP, Chief Legal Officer & Secretary | -7,75k | 6,51k | Verkauf | 0,84 | 187,62k | -3,97% |
| 2025-08-11 | Mr. Gregory MartiniInsider | -1,27k | 1,06k | Verkauf | 0,84 | 71,43k | -1,74% |